Ito Yoshiya, Abril Edward R, Bethea Nancy W, McCuskey Robert S
Deptartment of Cell Biology and Anatomy, College of Medicine, University of Arizona, Tucson, AZ 85724-5044, USA.
Am J Physiol Gastrointest Liver Physiol. 2004 Jan;286(1):G60-7. doi: 10.1152/ajpgi.00217.2003. Epub 2003 Sep 11.
Nitric oxide (NO) is suggested to play a role in liver injury elicited by acetaminophen (APAP). Hepatic microcirculatory dysfunction also is reported to contribute to the development of the injury. As a result, the role of NO in hepatic microcirculatory alterations in response to APAP was examined in mice by in vivo microscopy. A selective inducible NO synthase (iNOS) inhibitor,l-N6-(1-iminoethyl)-lysine (L-NIL), or a nonselective NOS inhibitor, NG-nitro-l-arginine methyl ester (L-NAME), was intraperitoneally administered to animals 10 min before APAP gavage. L-NIL suppressed raised alanine aminotransferase (ALT) values 6 h after APAP, whereas L-NAME increased those 1.7-fold. Increased ALT levels were associated with hepatic expression of iNOS. L-NIL, but not L-NAME, reduced the expression. APAP caused a reduction (20%) in the numbers of perfused sinusoids. L-NIL restored the sinusoidal perfusion, but L-NAME was ineffective. APAP increased the area occupied by infiltrated erythrocytes into the extrasinusoidal space. L-NIL tended to minimize this infiltration, whereas L-NAME further enhanced it. APAP caused an increase (1.5-fold) in Kupffer cell phagocytic activity. This activity in response to APAP was blunted by L-NIL, whereas L-NAME further elevated it. L-NIL suppressed APAP-induced decreases in hepatic glutathione levels. These results suggest that NO derived from iNOS contributes to APAP-induced parenchymal cell injury and hepatic microcirculatory disturbances. L-NIL exerts preventive effects on the liver injury partly by inhibiting APAP bioactivation. In contrast, NO derived from constitutive isoforms of NOS exerts a protective role in liver microcirculation against APAP intoxication and thereby minimizes liver injury.
一氧化氮(NO)被认为在对乙酰氨基酚(APAP)引发的肝损伤中起作用。据报道,肝微循环功能障碍也促成了这种损伤的发展。因此,通过体内显微镜检查在小鼠中研究了NO在对APAP反应的肝微循环改变中的作用。在给动物灌胃APAP前10分钟,腹腔注射选择性诱导型一氧化氮合酶(iNOS)抑制剂L-N6-(1-亚氨基乙基)-赖氨酸(L-NIL)或非选择性一氧化氮合酶抑制剂NG-硝基-L-精氨酸甲酯(L-NAME)。L-NIL抑制了APAP给药6小时后升高的丙氨酸转氨酶(ALT)值,而L-NAME使其升高了1.7倍。ALT水平升高与iNOS的肝脏表达有关。L-NIL降低了这种表达,但L-NAME没有。APAP使灌注的肝血窦数量减少了20%。L-NIL恢复了肝血窦灌注,但L-NAME无效。APAP增加了浸润到肝血窦外空间的红细胞所占面积。L-NIL倾向于使这种浸润最小化,而L-NAME进一步增强了它。APAP使库普弗细胞吞噬活性增加了1.5倍。L-NIL减弱了对APAP的这种反应活性,而L-NAME进一步提高了它。L-NIL抑制了APAP诱导的肝脏谷胱甘肽水平降低。这些结果表明,源自iNOS的NO促成了APAP诱导的实质细胞损伤和肝微循环紊乱。L-NIL部分通过抑制APAP生物活化对肝损伤发挥预防作用。相反,源自组成型一氧化氮合酶亚型的NO在肝微循环中对APAP中毒发挥保护作用,从而使肝损伤最小化。